Navigation Links
Misonix Reports First Quarter Fiscal 2010 Financial Results
Date:11/16/2009

With the exception of historical information contained in this press release, content herein may contain "forward looking statements" that are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Investors are cautioned that forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the statements made. These factors include general economic conditions, delays and risks associated with the performance of contracts, risks associated with international sales and currency fluctuations, uncertainties as a result of research and development, acceptable results from clinical studies, including publication of results and patient/procedure data with varying levels of statistical relevancy, risks involved in introducing and marketing new products, potential acquisitions, consumer and industry acceptance, litigation and/or court proceedings, including the timing and monetary requirements of such activities, the timing of finding strategic partners and implementing such relationships, regulatory risks including approval of pending and/or contemplated 510(k) filings, the ability to achieve and maintain profitability in the Company's business lines, and other factors discussed in the Company's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company disclaims any obligation to update its forward-looking relationships.

                          MISONIX, INC. And Subsidiaries
                          Consolidated Balance Sheets

                                                               Derived from
                                                             Audited Financial
                                               Unaudited        Statements
                     
'/>"/>
SOURCE Misonix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
2. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
4. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
5. Misonix Schedules First Quarter 2010 Financial Results Conference Call; November 16, 2009 at 4:30 p.m. Eastern
6. Misonix Announces New Distribution Agreement for Saudi Arabia and Other Middle Eastern Countries
7. Misonix Announces New Distribution Agreement For The United Arab Emirates (UAE)
8. Misonix Announces New Distribution Agreement for Argentina
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Spherix Reports Second Quarter Earnings
11. Tapestry Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... BARCELONA , Spanje, July 4, 2015 ... SIR-Spheres® Y-90 harsmicrosferen aan eerstelijns chemotherapie voor ... de lever (mCRC) verlengt de progressievrije overleving ... met niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die ... grootste verbetering gezien in progressievrije overleving (PFS) ...
(Date:7/3/2015)... Mexique, July 3, 2015 ... les épidémies que sont l,hypertension, le diabète et ... de plateformes éducatives gratuites et d,une conférence majeure ... http://photos.prnewswire.com/prnh/20150630/227033 ) , Les ... ligne , Prendre en charge l,hypertension en ...
(Date:7/2/2015)... , July 3, 2015 ... adquisición del 100% de participación en ZAO "Biocom" ... adquisición marca la incursión de Lupin en el ... de RUB en ventas, colocándolo como uno de ... 2014 (IMS Health). Durante más de una década, ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... Direct from Positive Blood CulturesFaster Results to Help Clinicians ... and VEDBAEK, Denmark, April 28 AdvanDx today announced ... for all CE-IVD marked PNA FISH(R) tests in Europe. ... time from the original 2.5 hours to 90 minutes ...
... April 27 Men taking generic drugs may be ... adverse events than if they were using branded medications, ... Researchers presented a study at the 104th Annual Scientific ... generic substitutes for alpha blockers and 5-alpha reductase inhibitors ...
Cached Medicine Technology:AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe 2AdvanDx Launches Fast, 90 Minutes Protocol for All CE-IVD Marked PNA FISH(R) Tests in Europe 3Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms 2
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker ... at the University of Minnesota, they knew it would save the university energy ... an award-winning choice: the total energy savings after installation was an impressive 89 ...
(Date:7/2/2015)... Vancouver, BC (PRWEB) , ... July 02, 2015 , ... With summer in full swing, ... , Canada is one of the top spots for fishing in the world, and it’s ... and rivers of Ontario, Canada has great fish. , Recreational fishing is a huge ...
(Date:7/2/2015)... ... ... “ LIFX ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... the market. , According to the U.S. Department of Energy, it’s very important to ...
(Date:7/2/2015)... PEACHTREE CITY, GA (PRWEB) , ... July 02, ... ... or field sporting the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the ... physicians, fitness experts and athletic trainers. Their significant popularity has inspired four new, ...
(Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of his 80th birthday, Don ... awareness and money for the Pulmonary Hypertension Association (PHA). Stevenson began the walk ... Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning and is making his ...
Breaking Medicine News(10 mins):Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... 4 (HealthDay News) -- ,Most people who live near fast-food ... may put on a few extra pounds, according to a ... that living near fast-food restaurants and other unhealthy food outlets ... the past few decades. Researchers analyzed 30 years of ...
... combination of chemotherapy and radiation significantly improved the 5-year ... (NPC), according to a phase III study published Nov. ... Cancer Institute. Nasopharyngeal carcinoma is endemic ... has been the primary treatment. Although the National Comprehensive ...
... News) -- Over-the-counter "thyroid support" supplements commonly used for ... and may pose a health threat, a new study ... two kinds of thyroid hormones -- triiodothyronine (T3) and ... animal thyroid glands, according to senior investigator Dr. Victor ...
... one occurs. While errors should be avoided as much as ... not and will never be perfect; errors and adverse events ... the study, "Nurses, Perceptions of Error Reporting and Disclosure in ... Journal of Nursing Care Quality , the authors found ...
... clinical trial of the medical food Souvenaid confirmed that ... people with mild Alzheimer,s disease (AD). Results of ... at the 4th International Conference on Clinical Trials in ... Nov. 4, 2011 by Philip Scheltens, MD, PhD, Professor ...
... News) -- Delaying treatment for a herniated disc beyond six ... A study of nearly 1,200 U.S. patients found that ... disc symptoms had less pain and disability years later than ... in the study were older than 18 years and treated ...
Cached Medicine News:Health News:Fast-Food Outlets Nearby Might Not Cause Weight Gain 2Health News:Concurrent chemo and radiation confers survival benefit in nasopharyngeal carcinoma patients 2Health News:Buyer, Beware of Over-the-Counter Thyroid Supplements: Study 2Health News:New study from NYUCN is the first to look at nursing error disclosure in nursing homes 2Health News:Nutritional intervention helps in mild Alzheimer's disease 2Health News:Timing May Be Key to Successful Back Surgery 2
Unique V-lock strapping system prevents roll and shifting to provide secure shoulder immobilization...
Shoulder Subluxation Inhibitor (SSI) is an ideal bracing system to keep athletes on the field by reducing the risk of shoulder injury. The SSI is the only brace that allows TOTAL ANTERIOR RANGE OR MO...
... and Cronin, Inc. is ... Patient Footwear, Orthopedic Softgoods, ... Products. Our products are ... and available in the ...
... single size, the Sierra Universal Collar fits the ... the comfort and motion restriction needed to protect ... the right size for the right fit . ... size and compact design alleviate storage problems, the ...
Medicine Products: